ID

35558

Description

Eliminate Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02245087

Lien

https://clinicaltrials.gov/show/NCT02245087

Mots-clés

Versions (1)
  1. 08/03/2019 08/03/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

8 mars 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Coronary Artery Disease NCT02245087

Anglais

Eligibility Coronary Artery Disease NCT02245087

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men 35-50 years of age
Description

Gender | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
women 45 - 59 years of age (must be sterile or >2 years postmenopausal)
Description

Gender | Age | Female Sterilization | Postmenopausal state

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0015787
UMLS CUI [4]
C0232970
ldl cholesterol greater than 1.8 mmol/l (70 mg/dl) based on testing performed within 1 year
Description

Serum LDL cholesterol measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0428474
one risk factor for coronary heart disease other than lipid abnormality:
Description

Risk factor Quantity Coronary heart disease | Exception Lipid abnormality

Type de données

boolean

Alias
UMLS CUI [1,1]
C0035648
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0010068
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0549634
hypertension [bp >140 mmhg systolic]
Description

Hypertensive disease | Systolic Pressure

Type de données

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0871470
family history of premature myocardial infarction [<60 years]
Description

Family history Myocardial Infarction Early

Type de données

boolean

Alias
UMLS CUI [1,1]
C0241889
UMLS CUI [1,2]
C0027051
UMLS CUI [1,3]
C1279919
south asian ethnic history
Description

South Asian

Type de données

boolean

Alias
UMLS CUI [1]
C1519427
currently smoking
Description

Tobacco use

Type de données

boolean

Alias
UMLS CUI [1]
C0543414
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
currently taking cholesterol lowering medication
Description

Anticholesteremic Agents

Type de données

boolean

Alias
UMLS CUI [1]
C0003277
qualify for cholesterol lowering medication based on current guidelines
Description

Qualification Anticholesteremic Agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C1709790
UMLS CUI [1,2]
C0003277
significant renal dysfunction (creatinine clearance <30 ml/min)
Description

Renal dysfunction | Creatinine clearance measurement

Type de données

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0373595
significant hepatic dysfunction (ast/alt >2.0 times upper limit of normal)
Description

Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
active malignancy
Description

Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
diabetes
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
progressive or terminal illness, or other condition in which subject is unlikely to survive the study period
Description

Progressive Disease | Terminal illness | Condition Survival aspects Completion of clinical trial Unlikely

Type de données

boolean

Alias
UMLS CUI [1]
C1335499
UMLS CUI [2]
C0679247
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0220921
UMLS CUI [3,3]
C2732579
UMLS CUI [3,4]
C0750558
known allergy, hypersensitivity (anaphylaxis) ar adverse reaction to any statin
Description

Statin allergy | Anaphylaxis Statins | Adverse reactions Statins

Type de données

boolean

Alias
UMLS CUI [1]
C0571873
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0360714
UMLS CUI [3,1]
C0559546
UMLS CUI [3,2]
C0360714
participation in a clinical trial (except observational studies) within previous 30 days
Description

Study Subject Participation Status | Exception Observational Study

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1518527
received any investigation product within 30 days prior to participation in this clinical trial
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
previously enrolled in this clinical trial
Description

Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
Retour au début de la page

Similar models

Eligibility Coronary Artery Disease NCT02245087

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
men 35-50 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Age | Female Sterilization | Postmenopausal state
Item
women 45 - 59 years of age (must be sterile or >2 years postmenopausal)
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0232970 (UMLS CUI [4])
Serum LDL cholesterol measurement
Item
ldl cholesterol greater than 1.8 mmol/l (70 mg/dl) based on testing performed within 1 year
boolean
C0428474 (UMLS CUI [1])
Risk factor Quantity Coronary heart disease | Exception Lipid abnormality
Item
one risk factor for coronary heart disease other than lipid abnormality:
boolean
C0035648 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0010068 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0549634 (UMLS CUI [2,2])
Hypertensive disease | Systolic Pressure
Item
hypertension [bp >140 mmhg systolic]
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
Family history Myocardial Infarction Early
Item
family history of premature myocardial infarction [<60 years]
boolean
C0241889 (UMLS CUI [1,1])
C0027051 (UMLS CUI [1,2])
C1279919 (UMLS CUI [1,3])
South Asian
Item
south asian ethnic history
boolean
C1519427 (UMLS CUI [1])
Tobacco use
Item
currently smoking
boolean
C0543414 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Anticholesteremic Agents
Item
currently taking cholesterol lowering medication
boolean
C0003277 (UMLS CUI [1])
Qualification Anticholesteremic Agents
Item
qualify for cholesterol lowering medication based on current guidelines
boolean
C1709790 (UMLS CUI [1,1])
C0003277 (UMLS CUI [1,2])
Renal dysfunction | Creatinine clearance measurement
Item
significant renal dysfunction (creatinine clearance <30 ml/min)
boolean
C3279454 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
significant hepatic dysfunction (ast/alt >2.0 times upper limit of normal)
boolean
C0086565 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Malignant Neoplasms
Item
active malignancy
boolean
C0006826 (UMLS CUI [1])
Diabetes Mellitus
Item
diabetes
boolean
C0011849 (UMLS CUI [1])
Progressive Disease | Terminal illness | Condition Survival aspects Completion of clinical trial Unlikely
Item
progressive or terminal illness, or other condition in which subject is unlikely to survive the study period
boolean
C1335499 (UMLS CUI [1])
C0679247 (UMLS CUI [2])
C0348080 (UMLS CUI [3,1])
C0220921 (UMLS CUI [3,2])
C2732579 (UMLS CUI [3,3])
C0750558 (UMLS CUI [3,4])
Statin allergy | Anaphylaxis Statins | Adverse reactions Statins
Item
known allergy, hypersensitivity (anaphylaxis) ar adverse reaction to any statin
boolean
C0571873 (UMLS CUI [1])
C0002792 (UMLS CUI [2,1])
C0360714 (UMLS CUI [2,2])
C0559546 (UMLS CUI [3,1])
C0360714 (UMLS CUI [3,2])
Study Subject Participation Status | Exception Observational Study
Item
participation in a clinical trial (except observational studies) within previous 30 days
boolean
C2348568 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1518527 (UMLS CUI [2,2])
Investigational New Drugs
Item
received any investigation product within 30 days prior to participation in this clinical trial
boolean
C0013230 (UMLS CUI [1])
Study Subject Participation Status
Item
previously enrolled in this clinical trial
boolean
C2348568 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial